epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Aimovig (erenumab-aooe)

erenumab

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  INJ (auto-injector): 70 mg, 140 mg; INJ (pre-filled syringe): 70 mg per mL, 140 mg per mL

Special Note

[drug name clarification]
Info: nonproprietary name = erenumab-aooe

migraine prophylaxis

[70-140 mg SC qmo]

renal dosing

[see below]
eGFR >30: no adjustment; eGFR <30: not defined
HD/PD: not defined

hepatic dosing

[not defined]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@56ae0ae8
  • hypersensitivity to drug or ingredient
  • caution: HTN
  • caution: Raynaud phenomenon

Drug Interactions .

Overview

erenumab

CGRP antagonist

Interaction Characteristics:
  • decreases gastrointestinal motility
  • hypertensive effects

Avoid/Use Alternative

  • atogepant
  • Aimovig (erenumab-aooe) (erenumab)
    +
    atogepant
    1 interaction

    Avoid/Use Alternative

    erenumab + atogepant

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • benztropine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    benztropine
    1 interaction

    Avoid/Use Alternative

    erenumab + benztropine

    consider alternative: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • clozapine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    clozapine
    1 interaction

    Avoid/Use Alternative

    erenumab + clozapine

    consider alternative: combo may incr. risk of severe constipation, paralytic ileus, including life-threatening (additive effects)

  • eluxadoline
  • Aimovig (erenumab-aooe) (erenumab)
    +
    eluxadoline
    1 interaction

    Avoid/Use Alternative

    erenumab + eluxadoline

    avoid combo: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • epinephrine inhaled
  • Aimovig (erenumab-aooe) (erenumab)
    +
    epinephrine inhaled
    1 interaction

    Avoid/Use Alternative

    erenumab + epinephrine inhaled

    avoid combo: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • eptinezumab
  • Aimovig (erenumab-aooe) (erenumab)
    +
    eptinezumab
    1 interaction

    Avoid/Use Alternative

    erenumab + eptinezumab

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • fremanezumab
  • Aimovig (erenumab-aooe) (erenumab)
    +
    fremanezumab
    1 interaction

    Avoid/Use Alternative

    erenumab + fremanezumab

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • furosemide
  • Aimovig (erenumab-aooe) (erenumab)
    +
    furosemide
    1 interaction

    Avoid/Use Alternative

    erenumab + furosemide

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • galcanezumab
  • Aimovig (erenumab-aooe) (erenumab)
    +
    galcanezumab
    1 interaction

    Avoid/Use Alternative

    erenumab + galcanezumab

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • midodrine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    midodrine
    1 interaction

    Avoid/Use Alternative

    erenumab + midodrine

    use alternative or monitor BP: combo may incr. risk of HTN (additive effects)

  • olanzapine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    olanzapine
    1 interaction

    Avoid/Use Alternative

    erenumab + olanzapine

    consider alternative: combo may incr. risk of severe constipation, paralytic ileus, including life-threatening (additive effects)

  • pramlintide
  • Aimovig (erenumab-aooe) (erenumab)
    +
    pramlintide
    1 interaction

    Avoid/Use Alternative

    erenumab + pramlintide

    consider alternative: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • rimegepant
  • Aimovig (erenumab-aooe) (erenumab)
    +
    rimegepant
    1 interaction

    Avoid/Use Alternative

    erenumab + rimegepant

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • ubrogepant
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ubrogepant
    1 interaction

    Avoid/Use Alternative

    erenumab + ubrogepant

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • zavegepant
  • Aimovig (erenumab-aooe) (erenumab)
    +
    zavegepant
    1 interaction

    Avoid/Use Alternative

    erenumab + zavegepant

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

Monitor/Modify Tx

  • abiraterone acetate
  • Aimovig (erenumab-aooe) (erenumab)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    erenumab + abiraterone acetate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • acebutolol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    erenumab + acebutolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • albuterol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    albuterol
    1 interaction

    Monitor/Modify Tx

    erenumab + albuterol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • albuterol inhaled
  • Aimovig (erenumab-aooe) (erenumab)
    +
    albuterol inhaled
    1 interaction

    Monitor/Modify Tx

    erenumab + albuterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • aliskiren
  • Aimovig (erenumab-aooe) (erenumab)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    erenumab + aliskiren

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • almotriptan
  • Aimovig (erenumab-aooe) (erenumab)
    +
    almotriptan
    1 interaction

    Monitor/Modify Tx

    erenumab + almotriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • amiloride
  • Aimovig (erenumab-aooe) (erenumab)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    erenumab + amiloride

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amlodipine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    erenumab + amlodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amphetamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    amphetamine
    1 interaction

    Monitor/Modify Tx

    erenumab + amphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • angiotensin II
  • Aimovig (erenumab-aooe) (erenumab)
    +
    angiotensin II
    1 interaction

    Monitor/Modify Tx

    erenumab + angiotensin II

    monitor BP: combo may incr. risk of HTN (additive effects)

  • aprocitentan
  • Aimovig (erenumab-aooe) (erenumab)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    erenumab + aprocitentan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • arformoterol inhaled
  • Aimovig (erenumab-aooe) (erenumab)
    +
    arformoterol inhaled
    1 interaction

    Monitor/Modify Tx

    erenumab + arformoterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • armodafinil
  • Aimovig (erenumab-aooe) (erenumab)
    +
    armodafinil
    1 interaction

    Monitor/Modify Tx

    erenumab + armodafinil

    monitor BP: combo may incr. risk of HTN (additive effects)

  • asciminib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    erenumab + asciminib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atenolol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    erenumab + atenolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atomoxetine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    atomoxetine
    1 interaction

    Monitor/Modify Tx

    erenumab + atomoxetine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atropine ophthalmic
  • Aimovig (erenumab-aooe) (erenumab)
    +
    atropine ophthalmic
    1 interaction

    Monitor/Modify Tx

    erenumab + atropine ophthalmic

    monitor BP: combo may incr. risk of HTN (additive effects)

  • axitinib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    erenumab + axitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • azilsartan medoxomil
  • Aimovig (erenumab-aooe) (erenumab)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    erenumab + azilsartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benazepril
  • Aimovig (erenumab-aooe) (erenumab)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    erenumab + benazepril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benzphetamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    benzphetamine
    1 interaction

    Monitor/Modify Tx

    erenumab + benzphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • betamethasone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    betamethasone
    1 interaction

    Monitor/Modify Tx

    erenumab + betamethasone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • betaxolol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    erenumab + betaxolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bevacizumab
  • Aimovig (erenumab-aooe) (erenumab)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    erenumab + bevacizumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bismuth subsalicylate
  • Aimovig (erenumab-aooe) (erenumab)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    erenumab + bismuth subsalicylate

    monitor BP w/ high-dose bismuth subsalicylate: combo may incr. risk of HTN (additive effects)

  • bisoprolol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    erenumab + bisoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • brigatinib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    brigatinib
    1 interaction

    Monitor/Modify Tx

    erenumab + brigatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • budesonide
  • Aimovig (erenumab-aooe) (erenumab)
    +
    budesonide
    1 interaction

    Monitor/Modify Tx

    erenumab + budesonide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bumetanide
  • Aimovig (erenumab-aooe) (erenumab)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    erenumab + bumetanide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bupropion
  • Aimovig (erenumab-aooe) (erenumab)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    erenumab + bupropion

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cabozantinib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    erenumab + cabozantinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • caffeine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    caffeine
    1 interaction

    Monitor/Modify Tx

    erenumab + caffeine

    monitor BP; avoid excessive caffeine intake: combo may incr. risk of HTN (additive effects)

  • caffeine citrate
  • Aimovig (erenumab-aooe) (erenumab)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    erenumab + caffeine citrate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • candesartan cilexetil
  • Aimovig (erenumab-aooe) (erenumab)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    erenumab + candesartan cilexetil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cannabis
  • Aimovig (erenumab-aooe) (erenumab)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    erenumab + cannabis

    monitor BP: combo may incr. risk of HTN (additive effects)

  • captopril
  • Aimovig (erenumab-aooe) (erenumab)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    erenumab + captopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • carfilzomib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    erenumab + carfilzomib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • carvedilol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    erenumab + carvedilol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • celecoxib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    erenumab + celecoxib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • chlorothiazide
  • Aimovig (erenumab-aooe) (erenumab)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    erenumab + chlorothiazide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • chlorthalidone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    erenumab + chlorthalidone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clevidipine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    erenumab + clevidipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clonidine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    clonidine
    1 interaction

    Monitor/Modify Tx

    erenumab + clonidine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cocaine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    cocaine
    1 interaction

    Monitor/Modify Tx

    erenumab + cocaine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • copanlisib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    erenumab + copanlisib

    monitor BP: combo may incr. risk of HTN (additive effects; copanlisib may cause infusion-related HTN)

  • corticotropin
  • Aimovig (erenumab-aooe) (erenumab)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    erenumab + corticotropin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cortisone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    cortisone
    1 interaction

    Monitor/Modify Tx

    erenumab + cortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cyclosporine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    erenumab + cyclosporine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • danazol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    erenumab + danazol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • darbepoetin alfa
  • Aimovig (erenumab-aooe) (erenumab)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    erenumab + darbepoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • deflazacort
  • Aimovig (erenumab-aooe) (erenumab)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    erenumab + deflazacort

    monitor BP: combo may incr. risk of HTN (additive effects)

  • desmopressin
  • Aimovig (erenumab-aooe) (erenumab)
    +
    desmopressin
    1 interaction

    Monitor/Modify Tx

    erenumab + desmopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • desvenlafaxine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    desvenlafaxine
    1 interaction

    Monitor/Modify Tx

    erenumab + desvenlafaxine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dexamethasone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    erenumab + dexamethasone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dexmethylphenidate
  • Aimovig (erenumab-aooe) (erenumab)
    +
    dexmethylphenidate
    1 interaction

    Monitor/Modify Tx

    erenumab + dexmethylphenidate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dextroamphetamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    dextroamphetamine
    1 interaction

    Monitor/Modify Tx

    erenumab + dextroamphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diclofenac
  • Aimovig (erenumab-aooe) (erenumab)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    erenumab + diclofenac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diclofenac topical
  • Aimovig (erenumab-aooe) (erenumab)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    erenumab + diclofenac topical

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diethylpropion
  • Aimovig (erenumab-aooe) (erenumab)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    erenumab + diethylpropion

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diflunisal
  • Aimovig (erenumab-aooe) (erenumab)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    erenumab + diflunisal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dihydroergotamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    dihydroergotamine
    1 interaction

    Monitor/Modify Tx

    erenumab + dihydroergotamine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • diltiazem
  • Aimovig (erenumab-aooe) (erenumab)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    erenumab + diltiazem

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dobutamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    dobutamine
    1 interaction

    Monitor/Modify Tx

    erenumab + dobutamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dopamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    dopamine
    1 interaction

    Monitor/Modify Tx

    erenumab + dopamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxapram
  • Aimovig (erenumab-aooe) (erenumab)
    +
    doxapram
    1 interaction

    Monitor/Modify Tx

    erenumab + doxapram

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxazosin
  • Aimovig (erenumab-aooe) (erenumab)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    erenumab + doxazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dronabinol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    erenumab + dronabinol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • droxidopa
  • Aimovig (erenumab-aooe) (erenumab)
    +
    droxidopa
    1 interaction

    Monitor/Modify Tx

    erenumab + droxidopa

    monitor BP: combo may incr. risk of supine HTN (additive effects)

  • eletriptan
  • Aimovig (erenumab-aooe) (erenumab)
    +
    eletriptan
    1 interaction

    Monitor/Modify Tx

    erenumab + eletriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • enalapril
  • Aimovig (erenumab-aooe) (erenumab)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    erenumab + enalapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • enalaprilat
  • Aimovig (erenumab-aooe) (erenumab)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    erenumab + enalaprilat

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedra
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ephedra
    1 interaction

    Monitor/Modify Tx

    erenumab + ephedra

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ephedrine injection
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ephedrine injection
    1 interaction

    Monitor/Modify Tx

    erenumab + ephedrine injection

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ephedrine oral
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ephedrine oral
    1 interaction

    Monitor/Modify Tx

    erenumab + ephedrine oral

    monitor BP: combo may incr. risk of HTN (additive effects)

  • epinephrine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    epinephrine
    1 interaction

    Monitor/Modify Tx

    erenumab + epinephrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • eplerenone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    erenumab + eplerenone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoetin alfa
  • Aimovig (erenumab-aooe) (erenumab)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    erenumab + epoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ergotamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ergotamine
    1 interaction

    Monitor/Modify Tx

    erenumab + ergotamine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • esketamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    erenumab + esketamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • esmolol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    erenumab + esmolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estetrol (contraceptive)
  • Aimovig (erenumab-aooe) (erenumab)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    erenumab + estetrol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • estradiol (contraceptive)
  • Aimovig (erenumab-aooe) (erenumab)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    erenumab + estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ethacrynic acid
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    erenumab + ethacrynic acid

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ethanol (alcoholic beverage)
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Monitor/Modify Tx

    erenumab + ethanol (alcoholic beverage)

    monitor BP: combo may incr. risk of HTN (chronic alcohol use) (additive effects)

  • ethinyl estradiol (contraceptive)
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    erenumab + ethinyl estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etodolac
  • Aimovig (erenumab-aooe) (erenumab)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    erenumab + etodolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etrasimod
  • Aimovig (erenumab-aooe) (erenumab)
    +
    etrasimod
    1 interaction

    Monitor/Modify Tx

    erenumab + etrasimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • felodipine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    erenumab + felodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenfluramine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    fenfluramine
    1 interaction

    Monitor/Modify Tx

    erenumab + fenfluramine

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • fenoldopam
  • Aimovig (erenumab-aooe) (erenumab)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    erenumab + fenoldopam

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenoprofen
  • Aimovig (erenumab-aooe) (erenumab)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    erenumab + fenoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fingolimod
  • Aimovig (erenumab-aooe) (erenumab)
    +
    fingolimod
    1 interaction

    Monitor/Modify Tx

    erenumab + fingolimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fludrocortisone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    erenumab + fludrocortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • flurbiprofen
  • Aimovig (erenumab-aooe) (erenumab)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    erenumab + flurbiprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • formoterol inhaled
  • Aimovig (erenumab-aooe) (erenumab)
    +
    formoterol inhaled
    1 interaction

    Monitor/Modify Tx

    erenumab + formoterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fosinopril
  • Aimovig (erenumab-aooe) (erenumab)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    erenumab + fosinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fostamatinib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    fostamatinib
    1 interaction

    Monitor/Modify Tx

    erenumab + fostamatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • frovatriptan
  • Aimovig (erenumab-aooe) (erenumab)
    +
    frovatriptan
    1 interaction

    Monitor/Modify Tx

    erenumab + frovatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fruquintinib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    erenumab + fruquintinib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • guanfacine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    erenumab + guanfacine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hoodia
  • Aimovig (erenumab-aooe) (erenumab)
    +
    hoodia
    1 interaction

    Monitor/Modify Tx

    erenumab + hoodia

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hydralazine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    erenumab + hydralazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrochlorothiazide
  • Aimovig (erenumab-aooe) (erenumab)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    erenumab + hydrochlorothiazide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrocortisone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    erenumab + hydrocortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hydroxocobalamin IV
  • Aimovig (erenumab-aooe) (erenumab)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    erenumab + hydroxocobalamin IV

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ibrutinib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    erenumab + ibrutinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ibuprofen
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    erenumab + ibuprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • indapamide
  • Aimovig (erenumab-aooe) (erenumab)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    erenumab + indapamide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • indomethacin
  • Aimovig (erenumab-aooe) (erenumab)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    erenumab + indomethacin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • irbesartan
  • Aimovig (erenumab-aooe) (erenumab)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    erenumab + irbesartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • isradipine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    erenumab + isradipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ketamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    erenumab + ketamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ketoprofen
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    erenumab + ketoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ketorolac
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    erenumab + ketorolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • labetalol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    erenumab + labetalol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lanreotide
  • Aimovig (erenumab-aooe) (erenumab)
    +
    lanreotide
    1 interaction

    Monitor/Modify Tx

    erenumab + lanreotide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • leflunomide
  • Aimovig (erenumab-aooe) (erenumab)
    +
    leflunomide
    1 interaction

    Monitor/Modify Tx

    erenumab + leflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lenvatinib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    erenumab + lenvatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • levalbuterol inhaled
  • Aimovig (erenumab-aooe) (erenumab)
    +
    levalbuterol inhaled
    1 interaction

    Monitor/Modify Tx

    erenumab + levalbuterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • levomilnacipran
  • Aimovig (erenumab-aooe) (erenumab)
    +
    levomilnacipran
    1 interaction

    Monitor/Modify Tx

    erenumab + levomilnacipran

    monitor BP: combo may incr. risk of HTN (additive effects)

  • licorice
  • Aimovig (erenumab-aooe) (erenumab)
    +
    licorice
    1 interaction

    Monitor/Modify Tx

    erenumab + licorice

    monitor BP w/ large amounts of licorice: combo may incr. risk of HTN (additive effects)

  • lisdexamfetamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    lisdexamfetamine
    1 interaction

    Monitor/Modify Tx

    erenumab + lisdexamfetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lisinopril
  • Aimovig (erenumab-aooe) (erenumab)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    erenumab + lisinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lorlatinib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    erenumab + lorlatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • losartan
  • Aimovig (erenumab-aooe) (erenumab)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    erenumab + losartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lumacaftor/ivacaftor
  • Aimovig (erenumab-aooe) (erenumab)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Monitor/Modify Tx

    erenumab + lumacaftor/ ivacaftor

    monitor BP: combo may incr. risk of HTN (additive effects)

  • luspatercept
  • Aimovig (erenumab-aooe) (erenumab)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    erenumab + luspatercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • magnesium salicylate
  • Aimovig (erenumab-aooe) (erenumab)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    erenumab + magnesium salicylate

    monitor BP w/ high-dose magnesium salicylate: combo may incr. risk of HTN (additive effects)

  • meclofenamate
  • Aimovig (erenumab-aooe) (erenumab)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    erenumab + meclofenamate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • mefenamic acid
  • Aimovig (erenumab-aooe) (erenumab)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    erenumab + mefenamic acid

    monitor BP: combo may incr. risk of HTN (additive effects)

  • meloxicam
  • Aimovig (erenumab-aooe) (erenumab)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    erenumab + meloxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methamphetamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    methamphetamine
    1 interaction

    Monitor/Modify Tx

    erenumab + methamphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Aimovig (erenumab-aooe) (erenumab)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    erenumab + methoxy polyethylene glycol-epoetin beta

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methyldopa
  • Aimovig (erenumab-aooe) (erenumab)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    erenumab + methyldopa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylergonovine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    methylergonovine
    1 interaction

    Monitor/Modify Tx

    erenumab + methylergonovine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • methylphenidate
  • Aimovig (erenumab-aooe) (erenumab)
    +
    methylphenidate
    1 interaction

    Monitor/Modify Tx

    erenumab + methylphenidate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methylprednisolone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    methylprednisolone
    1 interaction

    Monitor/Modify Tx

    erenumab + methylprednisolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methyltestosterone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    erenumab + methyltestosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metoclopramide
  • Aimovig (erenumab-aooe) (erenumab)
    +
    metoclopramide
    1 interaction

    Monitor/Modify Tx

    erenumab + metoclopramide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metolazone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    erenumab + metolazone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • metoprolol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    erenumab + metoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • milnacipran
  • Aimovig (erenumab-aooe) (erenumab)
    +
    milnacipran
    1 interaction

    Monitor/Modify Tx

    erenumab + milnacipran

    monitor BP: combo may incr. risk of HTN (additive effects)

  • minoxidil
  • Aimovig (erenumab-aooe) (erenumab)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    erenumab + minoxidil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mirabegron
  • Aimovig (erenumab-aooe) (erenumab)
    +
    mirabegron
    1 interaction

    Monitor/Modify Tx

    erenumab + mirabegron

    monitor BP: combo may incr. risk of HTN (additive effects)

  • modafinil
  • Aimovig (erenumab-aooe) (erenumab)
    +
    modafinil
    1 interaction

    Monitor/Modify Tx

    erenumab + modafinil

    monitor BP: combo may incr. risk of HTN (additive effects)

  • moexipril
  • Aimovig (erenumab-aooe) (erenumab)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    erenumab + moexipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nabumetone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    erenumab + nabumetone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nadolol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    erenumab + nadolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naproxen
  • Aimovig (erenumab-aooe) (erenumab)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    erenumab + naproxen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • naratriptan
  • Aimovig (erenumab-aooe) (erenumab)
    +
    naratriptan
    1 interaction

    Monitor/Modify Tx

    erenumab + naratriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • naxitamab
  • Aimovig (erenumab-aooe) (erenumab)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    erenumab + naxitamab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nebivolol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    erenumab + nebivolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nicardipine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    erenumab + nicardipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nifedipine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    erenumab + nifedipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nimodipine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    erenumab + nimodipine

    monitor BP: combo may decr. nimodipine efficacy (antagonistic effects)

  • niraparib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    niraparib
    1 interaction

    Monitor/Modify Tx

    erenumab + niraparib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nisoldipine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    erenumab + nisoldipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • norepinephrine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    norepinephrine
    1 interaction

    Monitor/Modify Tx

    erenumab + norepinephrine

    monitor BP: combo may incr. risk of severe HTN (additive effects)

  • obinutuzumab
  • Aimovig (erenumab-aooe) (erenumab)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    erenumab + obinutuzumab

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • olmesartan medoxomil
  • Aimovig (erenumab-aooe) (erenumab)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    erenumab + olmesartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • olodaterol inhaled
  • Aimovig (erenumab-aooe) (erenumab)
    +
    olodaterol inhaled
    1 interaction

    Monitor/Modify Tx

    erenumab + olodaterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • osilodrostat
  • Aimovig (erenumab-aooe) (erenumab)
    +
    osilodrostat
    1 interaction

    Monitor/Modify Tx

    erenumab + osilodrostat

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxaprozin
  • Aimovig (erenumab-aooe) (erenumab)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    erenumab + oxaprozin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxymetazoline nasal
  • Aimovig (erenumab-aooe) (erenumab)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    erenumab + oxymetazoline nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxytocin
  • Aimovig (erenumab-aooe) (erenumab)
    +
    oxytocin
    1 interaction

    Monitor/Modify Tx

    erenumab + oxytocin

    monitor BP: combo may incr. risk of HTN, including life-threatening (additive effects)

  • ozanimod
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ozanimod
    1 interaction

    Monitor/Modify Tx

    erenumab + ozanimod

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • pazopanib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    erenumab + pazopanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • perindopril
  • Aimovig (erenumab-aooe) (erenumab)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    erenumab + perindopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pexidartinib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    pexidartinib
    1 interaction

    Monitor/Modify Tx

    erenumab + pexidartinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phendimetrazine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    phendimetrazine
    1 interaction

    Monitor/Modify Tx

    erenumab + phendimetrazine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenoxybenzamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    erenumab + phenoxybenzamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phentermine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    erenumab + phentermine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phentolamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    erenumab + phentolamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    phenylephrine
    1 interaction

    Monitor/Modify Tx

    erenumab + phenylephrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine injection
  • Aimovig (erenumab-aooe) (erenumab)
    +
    phenylephrine injection
    1 interaction

    Monitor/Modify Tx

    erenumab + phenylephrine injection

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine nasal
  • Aimovig (erenumab-aooe) (erenumab)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    erenumab + phenylephrine nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine ophthalmic
  • Aimovig (erenumab-aooe) (erenumab)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    erenumab + phenylephrine ophthalmic

    monitor BP; HTN risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may incr. risk of HTN (additive effects)

  • phenylephrine rectal
  • Aimovig (erenumab-aooe) (erenumab)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    erenumab + phenylephrine rectal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pindolol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    erenumab + pindolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • piroxicam
  • Aimovig (erenumab-aooe) (erenumab)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    erenumab + piroxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ponatinib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    erenumab + ponatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ponesimod
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ponesimod
    1 interaction

    Monitor/Modify Tx

    erenumab + ponesimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pralsetinib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    pralsetinib
    1 interaction

    Monitor/Modify Tx

    erenumab + pralsetinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • prazosin
  • Aimovig (erenumab-aooe) (erenumab)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    erenumab + prazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • prednisolone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    prednisolone
    1 interaction

    Monitor/Modify Tx

    erenumab + prednisolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • prednisone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    prednisone
    1 interaction

    Monitor/Modify Tx

    erenumab + prednisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • propranolol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    erenumab + propranolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pseudoephedrine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    erenumab + pseudoephedrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • quetiapine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    erenumab + quetiapine

    monitor BP, especially in pts <18 yo: combo may incr. risk of HTN, severe constipation, paralytic ileus (additive effects)

  • quinapril
  • Aimovig (erenumab-aooe) (erenumab)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    erenumab + quinapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ramipril
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    erenumab + ramipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ramucirumab
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    erenumab + ramucirumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • regorafenib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    regorafenib
    1 interaction

    Monitor/Modify Tx

    erenumab + regorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ripretinib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ripretinib
    1 interaction

    Monitor/Modify Tx

    erenumab + ripretinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rizatriptan
  • Aimovig (erenumab-aooe) (erenumab)
    +
    rizatriptan
    1 interaction

    Monitor/Modify Tx

    erenumab + rizatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ropinirole
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    erenumab + ropinirole

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rotigotine transdermal
  • Aimovig (erenumab-aooe) (erenumab)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    erenumab + rotigotine transdermal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • salmeterol inhaled
  • Aimovig (erenumab-aooe) (erenumab)
    +
    salmeterol inhaled
    1 interaction

    Monitor/Modify Tx

    erenumab + salmeterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • salsalate
  • Aimovig (erenumab-aooe) (erenumab)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    erenumab + salsalate

    monitor BP w/ high-dose salsalate: combo may incr. risk of HTN (additive effects)

  • selpercatinib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    selpercatinib
    1 interaction

    Monitor/Modify Tx

    erenumab + selpercatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • siponimod
  • Aimovig (erenumab-aooe) (erenumab)
    +
    siponimod
    1 interaction

    Monitor/Modify Tx

    erenumab + siponimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • solriamfetol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    solriamfetol
    1 interaction

    Monitor/Modify Tx

    erenumab + solriamfetol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sorafenib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    sorafenib
    1 interaction

    Monitor/Modify Tx

    erenumab + sorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • spironolactone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    erenumab + spironolactone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sulindac
  • Aimovig (erenumab-aooe) (erenumab)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    erenumab + sulindac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sumatriptan
  • Aimovig (erenumab-aooe) (erenumab)
    +
    sumatriptan
    1 interaction

    Monitor/Modify Tx

    erenumab + sumatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sunitinib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    erenumab + sunitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tacrolimus
  • Aimovig (erenumab-aooe) (erenumab)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    erenumab + tacrolimus

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tagraxofusp
  • Aimovig (erenumab-aooe) (erenumab)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    erenumab + tagraxofusp

    monitor BP: combo may incr. risk of HTN (additive effects)

  • telmisartan
  • Aimovig (erenumab-aooe) (erenumab)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    erenumab + telmisartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terazosin
  • Aimovig (erenumab-aooe) (erenumab)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    erenumab + terazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terbutaline
  • Aimovig (erenumab-aooe) (erenumab)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    erenumab + terbutaline

    monitor BP: combo may incr. risk of HTN (additive effects)

  • teriflunomide
  • Aimovig (erenumab-aooe) (erenumab)
    +
    teriflunomide
    1 interaction

    Monitor/Modify Tx

    erenumab + teriflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • testosterone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    erenumab + testosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • timolol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    erenumab + timolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tivozanib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    erenumab + tivozanib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • tolmetin
  • Aimovig (erenumab-aooe) (erenumab)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    erenumab + tolmetin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • torsemide
  • Aimovig (erenumab-aooe) (erenumab)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    erenumab + torsemide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • trametinib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    erenumab + trametinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • trandolapril
  • Aimovig (erenumab-aooe) (erenumab)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    erenumab + trandolapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • triamcinolone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    erenumab + triamcinolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • triamterene
  • Aimovig (erenumab-aooe) (erenumab)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    erenumab + triamterene

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vadadustat
  • Aimovig (erenumab-aooe) (erenumab)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    erenumab + vadadustat

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • valsartan
  • Aimovig (erenumab-aooe) (erenumab)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    erenumab + valsartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vamorolone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    erenumab + vamorolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vandetanib
  • Aimovig (erenumab-aooe) (erenumab)
    +
    vandetanib
    1 interaction

    Monitor/Modify Tx

    erenumab + vandetanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vasopressin
  • Aimovig (erenumab-aooe) (erenumab)
    +
    vasopressin
    1 interaction

    Monitor/Modify Tx

    erenumab + vasopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • venlafaxine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    venlafaxine
    1 interaction

    Monitor/Modify Tx

    erenumab + venlafaxine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • verapamil
  • Aimovig (erenumab-aooe) (erenumab)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    erenumab + verapamil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vilanterol inhaled
  • Aimovig (erenumab-aooe) (erenumab)
    +
    vilanterol inhaled
    1 interaction

    Monitor/Modify Tx

    erenumab + vilanterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • viloxazine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    viloxazine
    1 interaction

    Monitor/Modify Tx

    erenumab + viloxazine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • voclosporin
  • Aimovig (erenumab-aooe) (erenumab)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    erenumab + voclosporin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • yohimbe
  • Aimovig (erenumab-aooe) (erenumab)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    erenumab + yohimbe

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ziv-aflibercept
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    erenumab + ziv-aflibercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zolmitriptan
  • Aimovig (erenumab-aooe) (erenumab)
    +
    zolmitriptan
    1 interaction

    Monitor/Modify Tx

    erenumab + zolmitriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

Caution Advised

  • aclidinium inhaled
  • Aimovig (erenumab-aooe) (erenumab)
    +
    aclidinium inhaled
    1 interaction

    Caution Advised

    erenumab + aclidinium inhaled

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • alfentanil
  • Aimovig (erenumab-aooe) (erenumab)
    +
    alfentanil
    1 interaction

    Caution Advised

    erenumab + alfentanil

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • alosetron
  • Aimovig (erenumab-aooe) (erenumab)
    +
    alosetron
    1 interaction

    Caution Advised

    erenumab + alosetron

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • amantadine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    amantadine
    1 interaction

    Caution Advised

    erenumab + amantadine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • amitriptyline
  • Aimovig (erenumab-aooe) (erenumab)
    +
    amitriptyline
    1 interaction

    Caution Advised

    erenumab + amitriptyline

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • amoxapine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    amoxapine
    1 interaction

    Caution Advised

    erenumab + amoxapine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • atropine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    atropine
    1 interaction

    Caution Advised

    erenumab + atropine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • belladonna alkaloids
  • Aimovig (erenumab-aooe) (erenumab)
    +
    belladonna alkaloids
    1 interaction

    Caution Advised

    erenumab + belladonna alkaloids

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • brompheniramine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    brompheniramine
    1 interaction

    Caution Advised

    erenumab + brompheniramine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • buprenorphine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    buprenorphine
    1 interaction

    Caution Advised

    erenumab + buprenorphine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • butorphanol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    butorphanol
    1 interaction

    Caution Advised

    erenumab + butorphanol

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • carbinoxamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    carbinoxamine
    1 interaction

    Caution Advised

    erenumab + carbinoxamine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • chlophedianol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    chlophedianol
    1 interaction

    Caution Advised

    erenumab + chlophedianol

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • chlorcyclizine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    chlorcyclizine
    1 interaction

    Caution Advised

    erenumab + chlorcyclizine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • chlorpheniramine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    chlorpheniramine
    1 interaction

    Caution Advised

    erenumab + chlorpheniramine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • chlorpromazine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    chlorpromazine
    1 interaction

    Caution Advised

    erenumab + chlorpromazine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • clemastine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    clemastine
    1 interaction

    Caution Advised

    erenumab + clemastine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • clidinium
  • Aimovig (erenumab-aooe) (erenumab)
    +
    clidinium
    1 interaction

    Caution Advised

    erenumab + clidinium

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • clomipramine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    clomipramine
    1 interaction

    Caution Advised

    erenumab + clomipramine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • codeine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    codeine
    1 interaction

    Caution Advised

    erenumab + codeine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • cyclobenzaprine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    cyclobenzaprine
    1 interaction

    Caution Advised

    erenumab + cyclobenzaprine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • cyproheptadine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    cyproheptadine
    1 interaction

    Caution Advised

    erenumab + cyproheptadine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • darifenacin
  • Aimovig (erenumab-aooe) (erenumab)
    +
    darifenacin
    1 interaction

    Caution Advised

    erenumab + darifenacin

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • desipramine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    desipramine
    1 interaction

    Caution Advised

    erenumab + desipramine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • dexbrompheniramine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    dexbrompheniramine
    1 interaction

    Caution Advised

    erenumab + dexbrompheniramine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • dexchlorpheniramine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    dexchlorpheniramine
    1 interaction

    Caution Advised

    erenumab + dexchlorpheniramine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • dicyclomine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    dicyclomine
    1 interaction

    Caution Advised

    erenumab + dicyclomine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • difenoxin
  • Aimovig (erenumab-aooe) (erenumab)
    +
    difenoxin
    1 interaction

    Caution Advised

    erenumab + difenoxin

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • dihydrocodeine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    dihydrocodeine
    1 interaction

    Caution Advised

    erenumab + dihydrocodeine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • dimenhydrinate
  • Aimovig (erenumab-aooe) (erenumab)
    +
    dimenhydrinate
    1 interaction

    Caution Advised

    erenumab + dimenhydrinate

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • diphenhydramine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    diphenhydramine
    1 interaction

    Caution Advised

    erenumab + diphenhydramine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • diphenoxylate
  • Aimovig (erenumab-aooe) (erenumab)
    +
    diphenoxylate
    1 interaction

    Caution Advised

    erenumab + diphenoxylate

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • disopyramide
  • Aimovig (erenumab-aooe) (erenumab)
    +
    disopyramide
    1 interaction

    Caution Advised

    erenumab + disopyramide

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • doxepin
  • Aimovig (erenumab-aooe) (erenumab)
    +
    doxepin
    1 interaction

    Caution Advised

    erenumab + doxepin

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • doxepin topical
  • Aimovig (erenumab-aooe) (erenumab)
    +
    doxepin topical
    1 interaction

    Caution Advised

    erenumab + doxepin topical

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • doxylamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    doxylamine
    1 interaction

    Caution Advised

    erenumab + doxylamine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • fentanyl
  • Aimovig (erenumab-aooe) (erenumab)
    +
    fentanyl
    1 interaction

    Caution Advised

    erenumab + fentanyl

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • fesoterodine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    fesoterodine
    1 interaction

    Caution Advised

    erenumab + fesoterodine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • flavoxate
  • Aimovig (erenumab-aooe) (erenumab)
    +
    flavoxate
    1 interaction

    Caution Advised

    erenumab + flavoxate

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • fluphenazine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    fluphenazine
    1 interaction

    Caution Advised

    erenumab + fluphenazine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • glycopyrrolate
  • Aimovig (erenumab-aooe) (erenumab)
    +
    glycopyrrolate
    1 interaction

    Caution Advised

    erenumab + glycopyrrolate

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • glycopyrrolate inhaled
  • Aimovig (erenumab-aooe) (erenumab)
    +
    glycopyrrolate inhaled
    1 interaction

    Caution Advised

    erenumab + glycopyrrolate inhaled

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • glycopyrronium topical
  • Aimovig (erenumab-aooe) (erenumab)
    +
    glycopyrronium topical
    1 interaction

    Caution Advised

    erenumab + glycopyrronium topical

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • homatropine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    homatropine
    1 interaction

    Caution Advised

    erenumab + homatropine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • hydrocodone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    hydrocodone
    1 interaction

    Caution Advised

    erenumab + hydrocodone

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • hydromorphone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    hydromorphone
    1 interaction

    Caution Advised

    erenumab + hydromorphone

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • hydroxyzine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    hydroxyzine
    1 interaction

    Caution Advised

    erenumab + hydroxyzine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • hyoscyamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    hyoscyamine
    1 interaction

    Caution Advised

    erenumab + hyoscyamine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • imipramine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    imipramine
    1 interaction

    Caution Advised

    erenumab + imipramine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • ipratropium inhaled
  • Aimovig (erenumab-aooe) (erenumab)
    +
    ipratropium inhaled
    1 interaction

    Caution Advised

    erenumab + ipratropium inhaled

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • levorphanol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    levorphanol
    1 interaction

    Caution Advised

    erenumab + levorphanol

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • loperamide
  • Aimovig (erenumab-aooe) (erenumab)
    +
    loperamide
    1 interaction

    Caution Advised

    erenumab + loperamide

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • loxapine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    loxapine
    1 interaction

    Caution Advised

    erenumab + loxapine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • meclizine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    meclizine
    1 interaction

    Caution Advised

    erenumab + meclizine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • meperidine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    meperidine
    1 interaction

    Caution Advised

    erenumab + meperidine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • methadone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    methadone
    1 interaction

    Caution Advised

    erenumab + methadone

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • methscopolamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    methscopolamine
    1 interaction

    Caution Advised

    erenumab + methscopolamine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • mirtazapine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    mirtazapine
    1 interaction

    Caution Advised

    erenumab + mirtazapine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • molindone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    molindone
    1 interaction

    Caution Advised

    erenumab + molindone

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • morphine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    morphine
    1 interaction

    Caution Advised

    erenumab + morphine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • nalbuphine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    nalbuphine
    1 interaction

    Caution Advised

    erenumab + nalbuphine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • nortriptyline
  • Aimovig (erenumab-aooe) (erenumab)
    +
    nortriptyline
    1 interaction

    Caution Advised

    erenumab + nortriptyline

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • oliceridine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    oliceridine
    1 interaction

    Caution Advised

    erenumab + oliceridine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • opium
  • Aimovig (erenumab-aooe) (erenumab)
    +
    opium
    1 interaction

    Caution Advised

    erenumab + opium

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • orphenadrine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    orphenadrine
    1 interaction

    Caution Advised

    erenumab + orphenadrine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • oxybutynin
  • Aimovig (erenumab-aooe) (erenumab)
    +
    oxybutynin
    1 interaction

    Caution Advised

    erenumab + oxybutynin

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • oxycodone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    oxycodone
    1 interaction

    Caution Advised

    erenumab + oxycodone

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • oxymorphone
  • Aimovig (erenumab-aooe) (erenumab)
    +
    oxymorphone
    1 interaction

    Caution Advised

    erenumab + oxymorphone

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • pentazocine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    pentazocine
    1 interaction

    Caution Advised

    erenumab + pentazocine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • perphenazine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    perphenazine
    1 interaction

    Caution Advised

    erenumab + perphenazine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • pheniramine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    pheniramine
    1 interaction

    Caution Advised

    erenumab + pheniramine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • pimozide
  • Aimovig (erenumab-aooe) (erenumab)
    +
    pimozide
    1 interaction

    Caution Advised

    erenumab + pimozide

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • prochlorperazine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    prochlorperazine
    1 interaction

    Caution Advised

    erenumab + prochlorperazine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • promethazine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    promethazine
    1 interaction

    Caution Advised

    erenumab + promethazine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • protriptyline
  • Aimovig (erenumab-aooe) (erenumab)
    +
    protriptyline
    1 interaction

    Caution Advised

    erenumab + protriptyline

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • pyrilamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    pyrilamine
    1 interaction

    Caution Advised

    erenumab + pyrilamine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • remifentanil
  • Aimovig (erenumab-aooe) (erenumab)
    +
    remifentanil
    1 interaction

    Caution Advised

    erenumab + remifentanil

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • revefenacin inhaled
  • Aimovig (erenumab-aooe) (erenumab)
    +
    revefenacin inhaled
    1 interaction

    Caution Advised

    erenumab + revefenacin inhaled

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • scopolamine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    scopolamine
    1 interaction

    Caution Advised

    erenumab + scopolamine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • sofpironium topical
  • Aimovig (erenumab-aooe) (erenumab)
    +
    sofpironium topical
    1 interaction

    Caution Advised

    erenumab + sofpironium topical

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • solifenacin
  • Aimovig (erenumab-aooe) (erenumab)
    +
    solifenacin
    1 interaction

    Caution Advised

    erenumab + solifenacin

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • sufentanil
  • Aimovig (erenumab-aooe) (erenumab)
    +
    sufentanil
    1 interaction

    Caution Advised

    erenumab + sufentanil

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • tapentadol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    tapentadol
    1 interaction

    Caution Advised

    erenumab + tapentadol

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • thioridazine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    thioridazine
    1 interaction

    Caution Advised

    erenumab + thioridazine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • thiothixene
  • Aimovig (erenumab-aooe) (erenumab)
    +
    thiothixene
    1 interaction

    Caution Advised

    erenumab + thiothixene

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • tiotropium inhaled
  • Aimovig (erenumab-aooe) (erenumab)
    +
    tiotropium inhaled
    1 interaction

    Caution Advised

    erenumab + tiotropium inhaled

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • tolterodine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    tolterodine
    1 interaction

    Caution Advised

    erenumab + tolterodine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • tramadol
  • Aimovig (erenumab-aooe) (erenumab)
    +
    tramadol
    1 interaction

    Caution Advised

    erenumab + tramadol

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • trifluoperazine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    trifluoperazine
    1 interaction

    Caution Advised

    erenumab + trifluoperazine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • trihexyphenidyl
  • Aimovig (erenumab-aooe) (erenumab)
    +
    trihexyphenidyl
    1 interaction

    Caution Advised

    erenumab + trihexyphenidyl

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • trimipramine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    trimipramine
    1 interaction

    Caution Advised

    erenumab + trimipramine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • triprolidine
  • Aimovig (erenumab-aooe) (erenumab)
    +
    triprolidine
    1 interaction

    Caution Advised

    erenumab + triprolidine

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • trospium
  • Aimovig (erenumab-aooe) (erenumab)
    +
    trospium
    1 interaction

    Caution Advised

    erenumab + trospium

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

  • umeclidinium inhaled
  • Aimovig (erenumab-aooe) (erenumab)
    +
    umeclidinium inhaled
    1 interaction

    Caution Advised

    erenumab + umeclidinium inhaled

    caution advised: combo may incr. risk of severe constipation, paralytic ileus (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@263c2ba5
  • hypersensitivity reaction
  • anaphylaxis
  • constipation, severe
  • HTN
  • Raynaud phenomenon

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@386e28f0
  • injection site reaction
  • constipation
  • cramps
  • muscle spasms

Safety/Monitoring .

Monitoring Parameters
BP

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy; inadequate human data available; no known risk of fetal harm based on animal data at 20x recommended human dose

Pregnancy Registry

encourage patients to enroll in Genesis Pregnancy Registry at 1-833-244-4083 or www.genesispregnancyregistry.com

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding; no human data available to assess risk of infant harm or effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@59a975e

Metabolism: for erenumab: unknown; CYP450: none

Excretion: for erenumab: unknown; Half-life: 28 days

Subclass: CGRP Inhibitors ; Headache/Migraine

Mechanism of Action
for erenumab: blocks calcitonin gene-related peptide (CGRP) activity (monoclonal antibody)

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Amgen, Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@23c5244f

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

subcutaneous solution:

  • 70 mg/mL (1 sureclick autoinjector): $661.00
  • 140 mg/mL (1 sureclick autoinjector): $661.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information